Niramai's breast cancer screening test receives CE mark approval
Niramaiâs breast cancer screening test receives CE mark approval Niramaiâs breast cancer screening test receives CE mark approval 06 April 2021 | News NIRAMAIâs Thermalytix solution can now be applied to all countries of Europe, as well as applicable to many Asian, African and Middle-East countries. Niramai, the deep-tech healthcare company at Bengaluru offering an innovative AI-based, radiation-free breast cancer screening test has now received the prestigious CE mark approval, ISO 13485 and MDSAP (Medical Device Single Audit Programme) International Certifications. T...
Source: biospectrumindia.com